A Novel Intranasal Spray Device for the Administration of Nanoparticles to Rodents

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Medical Devices-transactions of The Asme

• Publication date

  2015-12-01

• Fields of study

  Medicine, Chemistry, Engineering

• Identifiers
  DOI 10.1115/1.4029907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Haloperidol-loaded intranasally administered lectin functionalized poly(ethylene glycol)-block-poly(D,L)-lactic-co-glycolic acid (PEG-PLGA) nanoparticles for the treatment of schizophrenia.

  2014cited by this paper
• Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review

  2012cited by this paper
• Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations

  2012cited by this paper
• Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration.

  2011cited by this paper
• Freeze-dried chitosan/pectin nasal inserts for antipsychotic drug delivery.

  2010cited by this paper
• Intranasal nanoemulsion based brain targeting drug delivery system of risperidone.

  2008cited by this paper
• Characterization of Deposition from Nasal Spray Devices Using A Computational Fluid Dynamics Model of The Human Nasal Passages

  2007cited by this paper
• Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration.

  2006cited by this paper
• Numerical modeling of turbulent and laminar airflow and odorant transport during sniffing in the human and rat nose.

  2006cited by this paper
• PLA-PEG particles as nasal protein carriers: the influence of the particle size.

  2005cited by this paper
• Enhanced liquid atomization: From flow-focusing to flow-blurring

  2005cited by this paper
• A novel method for endotracheal intubation of mice and rats used in imaging studies.

  2005cited by this paper
• Glycans and neural cell interactions

  2004cited by this paper
• Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmacodynamics.

  2003cited by this paper
• Nanotech approaches to drug delivery and imaging.

  2003cited by this paper
• Nasal drug delivery--possibilities, problems and solutions.

  2003cited by this paper
• Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

  2001cited by this paper
• Bioavailability of apomorphine following intranasal administration of mucoadhesive drug delivery systems in rabbits.

  1999cited by this paper
• Modulatory effects of PLG and its peptidomimetics on haloperidol-induced catalepsy in rats.

  1999cited by this paper
• Generation of Steady Liquid Microthreads and Micron-Sized Monodisperse Sprays in Gas Streams

  1998cited by this paper
• Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice.

  1997cited by this paper
• Studies on the metabolism of haloperidol (HP): the role of CYP3A in the production of the neurotoxic pyridinium metabolite HPP+ found in rat brain following ip administration of HP.

  1995cited by this paper
• Histochemical study of glycoconjugates in the nasal mucosa of the rat and guinea pig

  1992cited by this paper
• The distribution of a dopamine D2 receptor mRNA in rat brain

  1989cited by this paper
• Comparative morphometry of the nasal cavity in rats and mice.

  1982cited by this paper
• Neurometabolic and behavioural effects of haloperidol in relation to drug levels in serum and brain

  1977cited by this paper

• Synthesis and Application of Nanovanilloids for Localized Therapeutic Hypothermia after Traumatic Brain Injury.

  2025cites this paper
• Characterization of a custom 3D-printed microfluidic aerosolizer for enhanced nose-to-brain delivery of nanoemulsion.

  2025cites this paper
• Fabrication of Amisulpride Nanosuspension for Nose to Brain Delivery in the Potential Antipsychotic Treatment

  2024cites this paper
• Recent progress in the intranasal PLGA-based drug delivery for neurodegenerative diseases treatment

  2023cites this paper
• Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs

  2022cites this paper
• Mucoadhesion as a strategy to enhance the direct nose-to-brain drug delivery

  2021cites this paper
• Intranasal delivery of antipsychotic drugs.

  2017cites this paper